The GLX Technology
The glx signature
Our proprietary technology plucks glycocalyx components out from the blood and reassembles the signal through machine learning, producing a GLX fingerprint we call the GLX Signature.
Since the GLX is the first interaction between the blood and the rest of the body, the GLX Signature allows for early diagnosis, before damage has occured. The GLX Signature doubles as a tool for monitoring flares, treatment response and triples as a companion diagnostic for disease-modifying treatments, accelerating time-to-market through earlier and better patient recruitment, and proof-of-effect, a so-called ‘efficacy test’.